FindTrial
Sign In

A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses

A Single-Center, Cross-over, Pilot Study Evaluating Acuvue® Oasys® Lenses (Senofilcon A), 30-Day Bausch + Lomb PureVision (Balafilcon A), and Clariti® 1-Day (Somofilcon A) Lenses, for Their Impact on Ocular Discomfort Induced by Exposure to the Turbo Controlled Adverse Environment™

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02298400
Enrollment
0
Registered
2014-11-24
Start date
2014-08-31
Completion date
2014-09-30
Last updated
2024-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contact Lens Complication

Brief summary

The purpose of this study is to compare the comfort of three commercially available contact lenses.

Interventions

DEVICEAcuvue® Oasys® Lenses (senofilcon A)

Contact lenses placed in each eye during the day for about 8 hours

DEVICE30-Day Bausch + Lomb PureVision (balafilcon A)

Contact lenses placed in each eye during the day for about 8 hours

DEVICEClariti® 1-Day (Somofilcon A)

Contact lenses placed in each eye during the day for about 8 hours

Sponsors

ORA, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be at least 18 years old * Have provided written informed consent * Have discomfort when wearing contact lenses

Exclusion criteria

* Have an active ocular infection or significant slit lamp findings * Participated in any other studies in the past 30 days

Design outcomes

Primary

MeasureTime frame
Contact lens wear comfort, as assessed by subject reported symptoms in diaries.1 week

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026